메뉴 건너뛰기




Volumn 14, Issue 7, 2015, Pages 693-701

Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): A non-randomised, prospective, multicentre, open-label study

(20)  Timmermann, Lars a   Jain, Roshini b   Chen, Lilly b   Maarouf, Mohamed a   Barbe, Michael T a   Allert, Niels c   Brücke, Thomas d   Kaiser, Iris e   Beirer, Sebastian d   Sejio, Fernando f   Suarez, Esther f   Lozano, Beatriz f   Haegelen, Claire g   Vérin, Marc h   Porta, Mauro i   Servello, Domenico i   Gill, Steven j   Whone, Alan j   Van Dyck, Nic k   Alesch, Francois e  


Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; AGED; AKINESIA; ANXIETY; APATHY; APPLICATION SITE BLEEDING; ARTICLE; AUDITORY HALLUCINATION; BACKACHE; BRAIN DEPTH STIMULATION; CONFUSION; CYSTITIS; DIPLOPIA; DYSARTHRIA; DYSTONIA; FAINTNESS; FALLING; FEMALE; GAIT DISORDER; HELICOBACTER INFECTION; HUMAN; HYPESTHESIA; IMPLANTABLE DEPTH BRAIN STIMULATOR; IMPLANTABLE PULSE GENERATOR; INFLUENZA; INTERVENTION STUDY; LACERATION; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; MOTOR DYSFUNCTION; MULTICENTER STUDY; PARKINSON DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROSTHESIS DISLOCATION; RESPIRATION DEPRESSION; SIDE EFFECT; SPEECH DISORDER; SPRAIN; STAPHYLOCOCCUS INFECTION; SUBTHALAMIC NUCLEUS; SURGICAL INFECTION; UNIFIED PARKINSON DISEASE RATING SCALE; WEIGHT GAIN; CLINICAL TRIAL; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; HUMANS; INSTRUMENTATION; METHODS; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84930537768     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00087-3     Document Type: Article
Times cited : (137)

References (27)
  • 1
    • 0028796071 scopus 로고
    • Effects of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
    • Limousin P, Pollak P, Benazzouz A, et al. Effects of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995, 345:91-95.
    • (1995) Lancet , vol.345 , pp. 91-95
    • Limousin, P.1    Pollak, P.2    Benazzouz, A.3
  • 2
    • 33748139412 scopus 로고    scopus 로고
    • A randomized trial of deep brain stimulation for Parkinson's disease
    • Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep brain stimulation for Parkinson's disease. N Engl J Med 2006, 355:896-908.
    • (2006) N Engl J Med , vol.355 , pp. 896-908
    • Deuschl, G.1    Schade-Brittinger, C.2    Krack, P.3
  • 3
    • 58149385649 scopus 로고    scopus 로고
    • Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson's disease
    • Weaver F, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson's disease. JAMA 2009, 301:63-73.
    • (2009) JAMA , vol.301 , pp. 63-73
    • Weaver, F.1    Follett, K.2    Stern, M.3
  • 4
    • 77953169733 scopus 로고    scopus 로고
    • Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease
    • Follett K, Weaver F, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010, 362:2077-2091.
    • (2010) N Engl J Med , vol.362 , pp. 2077-2091
    • Follett, K.1    Weaver, F.2    Stern, M.3
  • 5
    • 77952320903 scopus 로고    scopus 로고
    • Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    • on behalf of the PD SURG Collaborative Group
    • Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010, 9:581-591. on behalf of the PD SURG Collaborative Group.
    • (2010) Lancet Neurol , vol.9 , pp. 581-591
    • Williams, A.1    Gill, S.2    Varma, T.3
  • 6
    • 84873675072 scopus 로고    scopus 로고
    • Neurostimulation for Parkinson's disease with early motor complications
    • Schuepbach W, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013, 368:610-622.
    • (2013) N Engl J Med , vol.368 , pp. 610-622
    • Schuepbach, W.1    Rau, J.2    Knudsen, K.3
  • 7
    • 84903547323 scopus 로고    scopus 로고
    • Steering technology for deep brain stimulation
    • Green A, Aziz T Steering technology for deep brain stimulation. Brain 2014, 137:1854-1856.
    • (2014) Brain , vol.137 , pp. 1854-1856
    • Green, A.1    Aziz, T.2
  • 8
    • 4644366495 scopus 로고    scopus 로고
    • Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease
    • Herzog J, Fietzek U, Hamel W, et al. Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease. Mov Disord 2004, 19:1050-1054.
    • (2004) Mov Disord , vol.19 , pp. 1050-1054
    • Herzog, J.1    Fietzek, U.2    Hamel, W.3
  • 9
    • 84923579965 scopus 로고    scopus 로고
    • The rationale driving the evolution of deep brain stimulation to constant-current devices
    • Bronstein J, Tagliati M, McIntyre C, et al. The rationale driving the evolution of deep brain stimulation to constant-current devices. Neuromodulation 2015, 18:85-89.
    • (2015) Neuromodulation , vol.18 , pp. 85-89
    • Bronstein, J.1    Tagliati, M.2    McIntyre, C.3
  • 10
    • 47049105323 scopus 로고    scopus 로고
    • Current steering to control the volume of tissue activated during deep brain stimulation
    • Butson C, McIntyre C Current steering to control the volume of tissue activated during deep brain stimulation. Brain Stimul 2008, 1:7-15.
    • (2008) Brain Stimul , vol.1 , pp. 7-15
    • Butson, C.1    McIntyre, C.2
  • 11
    • 84864438498 scopus 로고    scopus 로고
    • Current steering to activate targeted neural pathways during deep brain stimulation of the subthalamic region
    • Chaturvedi A, Foutz T, McIntyre C Current steering to activate targeted neural pathways during deep brain stimulation of the subthalamic region. Brain Stimul 2012, 5:369-377.
    • (2012) Brain Stimul , vol.5 , pp. 369-377
    • Chaturvedi, A.1    Foutz, T.2    McIntyre, C.3
  • 12
    • 84897962247 scopus 로고    scopus 로고
    • Multiple source current steering: a novel deep brain stimulation concept for customized programming in a Parkinson's disease patient
    • Barbe M, Maarouf M, Alesch F, Timmermann L Multiple source current steering: a novel deep brain stimulation concept for customized programming in a Parkinson's disease patient. Parkinsonism Relat Disord 2014, 20:471-473.
    • (2014) Parkinsonism Relat Disord , vol.20 , pp. 471-473
    • Barbe, M.1    Maarouf, M.2    Alesch, F.3    Timmermann, L.4
  • 13
    • 84895732392 scopus 로고    scopus 로고
    • Individualized current-shaping reduces DBS-induced dysarthria in patients with essential tremor
    • Barbe M, Dembek T, Becker J, et al. Individualized current-shaping reduces DBS-induced dysarthria in patients with essential tremor. Neurology 2014, 82:614-619.
    • (2014) Neurology , vol.82 , pp. 614-619
    • Barbe, M.1    Dembek, T.2    Becker, J.3
  • 14
    • 84903538806 scopus 로고    scopus 로고
    • Directional deep brain stimulation: an intraoperative double-blind pilot study
    • Pollo C, Kaelin-Lang A, Oertel M, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain 2014, 137:2015-2026.
    • (2014) Brain , vol.137 , pp. 2015-2026
    • Pollo, C.1    Kaelin-Lang, A.2    Oertel, M.3
  • 15
    • 0026515731 scopus 로고
    • Core assessment program for intracerebral transplantations (CAPIT)
    • Langston J, Widner H, Goetz C, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992, 7:2-13.
    • (1992) Mov Disord , vol.7 , pp. 2-13
    • Langston, J.1    Widner, H.2    Goetz, C.3
  • 16
    • 0033428823 scopus 로고    scopus 로고
    • Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
    • Defer G, Widner H, Marie R, Remy P, Leviver M Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999, 14:572-584.
    • (1999) Mov Disord , vol.14 , pp. 572-584
    • Defer, G.1    Widner, H.2    Marie, R.3    Remy, P.4    Leviver, M.5
  • 17
    • 78349261173 scopus 로고    scopus 로고
    • Systematic review of levodopa dose equivalency reporting in Parksinson's disease
    • Tomlinson C, Stowe R, Patel S, Rick C, Gray R, Clarke C Systematic review of levodopa dose equivalency reporting in Parksinson's disease. Mov Disord 2010, 25:2649-2653.
    • (2010) Mov Disord , vol.25 , pp. 2649-2653
    • Tomlinson, C.1    Stowe, R.2    Patel, S.3    Rick, C.4    Gray, R.5    Clarke, C.6
  • 18
    • 0043136549 scopus 로고    scopus 로고
    • Gatekeeping strategies for clinical trials that do not require all primary effects to be significant
    • Dmitrienko A, Offen W, Westfall P Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Stat Med 2003, 22:2387-2400.
    • (2003) Stat Med , vol.22 , pp. 2387-2400
    • Dmitrienko, A.1    Offen, W.2    Westfall, P.3
  • 19
    • 0031480089 scopus 로고    scopus 로고
    • Multiple hypothesis testing and weights
    • Benjamini Y, Hochberg Y Multiple hypothesis testing and weights. Scand J Stat 1997, 24:407-418.
    • (1997) Scand J Stat , vol.24 , pp. 407-418
    • Benjamini, Y.1    Hochberg, Y.2
  • 20
    • 84855987459 scopus 로고    scopus 로고
    • Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial
    • for the SJM DBS Study Group
    • Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol 2012, 11:140-149. for the SJM DBS Study Group.
    • (2012) Lancet Neurol , vol.11 , pp. 140-149
    • Okun, M.S.1    Gallo, B.V.2    Mandybur, G.3
  • 21
    • 54949151575 scopus 로고    scopus 로고
    • A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
    • Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008, 131:2720-2728.
    • (2008) Brain , vol.131 , pp. 2720-2728
    • Voon, V.1    Krack, P.2    Lang, A.E.3
  • 22
    • 84918816785 scopus 로고    scopus 로고
    • Myths and facts about the EARLYSTIM study
    • Schuepbach W, Rau J, Houeto J, et al. Myths and facts about the EARLYSTIM study. Mov Disord 2014, 29:1742-1750.
    • (2014) Mov Disord , vol.29 , pp. 1742-1750
    • Schuepbach, W.1    Rau, J.2    Houeto, J.3
  • 23
    • 84883798948 scopus 로고    scopus 로고
    • Longitudinal impedance variability in patients with chronically implanted DBS devices
    • Cheung T, Nuno M, Hoffman M, et al. Longitudinal impedance variability in patients with chronically implanted DBS devices. Brain Stimul 2013, 6:746-751.
    • (2013) Brain Stimul , vol.6 , pp. 746-751
    • Cheung, T.1    Nuno, M.2    Hoffman, M.3
  • 24
    • 32444437700 scopus 로고    scopus 로고
    • Sources and effects of electrode impedance during deep brain stimulation
    • Butson C, Maks C, McIntyre C Sources and effects of electrode impedance during deep brain stimulation. Clin Neurophysiol 2006, 117:447-454.
    • (2006) Clin Neurophysiol , vol.117 , pp. 447-454
    • Butson, C.1    Maks, C.2    McIntyre, C.3
  • 25
    • 84872276476 scopus 로고    scopus 로고
    • A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey
    • Timmermann L, Schupbach M, Hertel F, et al. A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey. Eur Neurol 2013, 69:193-199.
    • (2013) Eur Neurol , vol.69 , pp. 193-199
    • Timmermann, L.1    Schupbach, M.2    Hertel, F.3
  • 26
    • 79960799815 scopus 로고    scopus 로고
    • Open-label surgical trials for Parkinson's disease: time for reconsideration
    • Alterman R, Tagliati M, Olanow C Open-label surgical trials for Parkinson's disease: time for reconsideration. Ann Neurol 2011, 70:5-8.
    • (2011) Ann Neurol , vol.70 , pp. 5-8
    • Alterman, R.1    Tagliati, M.2    Olanow, C.3
  • 27
    • 33748320447 scopus 로고    scopus 로고
    • Minimal clinically important change on the unified Parkinson's disease rating scale
    • Schrag A, Sampaio C, Counsell N, Poewe W Minimal clinically important change on the unified Parkinson's disease rating scale. Mov Disord 2006, 21:1200-1207.
    • (2006) Mov Disord , vol.21 , pp. 1200-1207
    • Schrag, A.1    Sampaio, C.2    Counsell, N.3    Poewe, W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.